South Korea’s IP-backed lending market growth exceeds targets
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
The Korean chemicals giant will do anything to combat “harsh competition” and IP is one of the “crucial” tools for securing success, contends IP head Kyung-Hwa Min
The global scientific and engineering consultancy has bought TechPats, a patent-focused technical expert firm, at a time when an uncertain economy and declining number of M&As has led some companies to issue layoff notices to IP staff
Returning from two action-packed days in London, IAM Deputy Editor Adam Houldsworth reflects on the surprising state of corporate UPC strategies, the rise of AI, FRAND fireworks and more
02 April 2022
Patent value, IP finance and the challenges of digitisation were just some of the subjects discussed in front of a sell-out audience in London yesterday
31 March 2022
Two years after private equity buyout, the pioneering IP advisory firm led by Jim Malackowski changes hands again
30 March 2022
KAIST’s dispute with its own licensing arm may be a problem of the university’s own making, but it underlines the opacity of modern patent litigation
26 March 2022
ROI’s latest report on sales activity and reflections on 10 years of market tracking
02 March 2022
Some of the highest-value deals in intellectual property today are taking place in the burgeoning marketplace for revenue streams linked to pharmaceutical products
02 March 2022
Six things we learned about the transactions marketplace in a year that featured notable patent deals both big and small
02 March 2022
Richardson Oliver Insights highlights how the patent market has evolved to the point where it is not only a place to buy and sell assets.
02 March 2022
I have nothing but good things to say about the company but it's time to move on and do something new, says Joseph Kessler
01 March 2022
Roivant’s most recent spinout shows that it is still on the hunt for deprioritised life sciences patents
22 February 2022
Unlock unlimited access to all IAM content